OncoSuite Next Gen | Philips Healthcare

Live Image Guidance in the treatment of hypervascular tumors of the liver

As interventional oncology technology evolves, we are focused on finding new ways to help you treat the

entire hypervascular tumor in the liver and all their feeder vessels without affecting healthy tissue or organs.

Our next generation OncoSuite* with a greatly expanded version of XperCT Dual offers world’s first dedicated interventional imaging for the visualization of BTG LUMIᵀᴹ, ¹beads (www.LCBeadLUMI.com) used in the endovascular oncologic procedures of the liver.

The new Open Trajectory feature of XperCT Dual allows visualization of off-centered regions of interest, such as the periphery of the liver, in a single sweep².

Other features of XPerCT Dual include for example DualPhase and DualView. DualPhase allows one-step automatic reconstruction of arterial and delayed phase of contrast injection. DualView allows simultaneous visualization of two cone beam CT datasets (pre- and post).

With our Live Image Guidance, we aim to remove barriers to safer, more effective and reproducible treatments, delivering relevant clinical value where it’s needed most - at the point of patient treatment.

Download brochure (PDF)

Explore the latest and greatest of OncoSuite

Open Trajectory

Enhances visualization of off-centered regions of interest, like the periphery of the liver.

DualPhase Imaging

DualPhase Imaging provides visualization of the vascular structures present in the region of interest in the arterial phase and accumulation of contrast agent in the delayed phase.

World's first optimized imaging for radiopaque beads

Guides targeted delivery and tumor coverage.

“EmboGuide detects 50% more feeding blood vessels from the hepatic artery than standard DSA³, and the physicians’ burden can be considerably mitigated by the use of EmboGuide. We think it is a very useful software.”

Dr S. Miyayama, MD, Fukui-ken Saiseikai Hospital, Japan

“With the advance of Dual-Phase cone-beam CT there is really no need anymore for a combined Angio-CT or Angio-MR system.”

Dr. J. Geschwind, Professor and Chairman Radiology & Biomedical Imaging,

Yale School of Medicine, USA

References

1. Loffroy R et al. Cardiovasc Intervent Radiol. 2012; 38(2):929-31

2. Miyayama, S et al. J Vasc Interv Radiol. 2013; 24(4):501-8

3. Choo, JY et al. European Radiology. 2013; 23(3):712-9

4. Heusner TA et al. ROFO. 2010; 182:603–608

5. van den Hoven AF et al. Cardiovascular and interventional radiology. 216; 39(1): 64-73

6. Loffroy R et al. Radiology. 2013 Feb; 266(2):636-48

7. Miyayama S et al. Cardiovasc Intervent Radiol. 2014 Apr; 37(2):388-95

8. Suk Oh J et al. J Vasc Interv Radiol. 2013 Apr; 24(4):483-9

9. Pellerin, O et al. Cancer Biother Radiopharm. 2013 Jul; 28(6):459-65

10. Schernthaner RE et al. Radiology. 2015; 277(3):833–41

11. Levy EB et al. Cardiovasc Intervent Radiol. 2016; 39(8):1177-86

12. Higashihara et al. Eur Radiol. 2012 Apr; 22(4):872-9

Sign up to receive the CIRSE 2016 recordings from our key opinion leaders

How can we help you?

*

Contact information

* This field is mandatory

Country

*

First name*

First name (phonetic)

*

Last name*

Last name (phonetic)

Salutation

Academic title

*

Email address*

Business phone

*

Company*

Job title

Industry

*

Function

*

Specialty

*

Department

*

State or Province

City

Address

Zip or Postcode

By specifying your reason for contact we will be able to provide you with a better service.

We work with partners and distributors who may contact you about this Philips product on our behalf.

Follow up information

*

Preferred method of contact

Best time to call

Estimated time of purchase

*

Comments

What is cross border data transfer?

I agree on cross-border transfer of personal information.

CEE specific legal checkbox

I would like to receive marketing related communications about Philips products, services, events and promotions that may be relevant to me based on my user preferences and behaviour.

Final CEE consent

Making the difference with
Philips Live Image Guidance in Interventional Oncology

Live Image Guidance in the treatment of hypervascular tumors of the liver

Explore the latest and greatest of OncoSuite

“EmboGuide detects 50% more feeding blood vessels from the hepatic artery than standard DSA³, and the physicians’ burden can be considerably mitigated by the use of EmboGuide. We think it is a very useful software.”

“With the advance of Dual-Phase cone-beam CT there is really no need anymore for a combined Angio-CT or Angio-MR system.”

Related Solutions & Products

*OncoSuite is the Philips’ solution to assist physicians in embolization of hypervascular tumors in the liver and percutaneous ablation procedures in interventional oncology treatment. It is the combination of our innovative product offerings XperCT Dual, EmboGuide and XperGuide.

References

Sign up to receive the CIRSE 2016 recordings from our key opinion leaders

Contact information

Making the difference with Philips Live Image Guidance in Interventional Oncology

Live Image Guidance in the treatment of hypervascular tumors of the liver

Explore the latest and greatest of OncoSuite

“EmboGuide detects 50% more feeding blood vessels from the hepatic artery than standard DSA³, and the physicians’ burden can be considerably mitigated by the use of EmboGuide. We think it is a very useful software.”

“With the advance of Dual-Phase cone-beam CT there is really no need anymore for a combined Angio-CT or Angio-MR system.”

Related Solutions & Products

*OncoSuite is the Philips’ solution to assist physicians in embolization of hypervascular tumors in the liver and percutaneous ablation procedures in interventional oncology treatment. It is the combination of our innovative product offerings XperCT Dual, EmboGuide and XperGuide.

References

Sign up to receive the CIRSE 2016 recordings from our key opinion leaders

Contact information

Making the difference with
Philips Live Image Guidance in Interventional Oncology